Proteus mirabilis
Antibiotic |
% Susceptible |
Antibiotic |
% Susceptible |
|
| Ampicillin | 81 |
Imipenem | 100 |
|
| Azithromycin | -* |
Levofloxacin | 91 |
|
| Aztreonam | 98 |
Meropenem | 98 |
|
| Cefazolin | 87 |
Moxifloxacin | +
|
|
| Cefepime | 100 |
Nitrofurantoin | 0
|
|
| Ceftazidime | 99 |
Oxacillin/Naf | - |
|
| Ceftriaxone | 99 |
Penicillin | - |
|
| Cefuroxime | 95 |
Piperacillin | 85
|
|
| Ciprofloxacin | 82 |
Piperacillin/tazo | 100 |
|
| Clarithromycin | -* |
Ticarcillin/Clav | 99 |
|
| Clindamycin | -* |
Tobramycin | 97 |
|
| Doxycycline | -* |
TMP/SMX | 87 |
|
| Erythromycin | -* |
Unasyn/Aug | 97 |
|
| Gentamicin | 95 |
Vancomycin | -* |
|
Comments:
Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy 2007
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy 2007
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections